ABBOTT HTLV-I/HTLV-II-EIA 7A92-32

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04,05 report with the FDA on 2007-08-09 for ABBOTT HTLV-I/HTLV-II-EIA 7A92-32 manufactured by Abbott Laboratories.

Event Text Entries

[22052245] Preliminary investigation: to troubleshoot the issue, the abbott technical specialist watched the account's fpc pipette the htlv-i/ii assay and noticed that the 5 ul sample failed the dispense into the wall and instead clung to the fpc pipette tip. The failure to dispense into the well was not flagged by the fpc, so the run was stopped manually and no data was generated. Service performed a realignment of the fpc. In a recent abbott study using the htlv-i/ii assay, the absorbance values generated when no specimen was dispensed ranged from 0. 004 to 0. 040, which demonstrated that the assay is able to produce valid results when no specimen is dispensed. The lower limit range for specimen read on the ppc is 0. 005, therefore values greater than 0. 005 fall within the valid range of the ppc. The ppc readings do not identify the missing specimen as a low invalid. Negative results are generated for wells without specimen added which could result in false negative results for positive specimens. This is an initial report. Further investigation is in process. A final report will be submitted when the investigation is completed.
Patient Sequence No: 1, Text Type: N, H10


[22185976] The account noticed an increased number of low flags while processing the htlv-i/ii eia assay. The account stated that during the past month, every htlv-i/ii run had 3 to 22 low flags per run. The placement of the low flags has been random on the tray wells and has been seen across all commander fpc's and commander ppc's at the account. No low flags have been generated on abbott or external controls and all controls have been in range. Service was requested for the commander fpc's and commander ppc's at the account. No impact to patient management has been reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1415939-2007-00207
MDR Report Key893438
Report Source04,05
Date Received2007-08-09
Date of Report2007-07-12
Date of Event2007-05-15
Date Mfgr Received2007-07-12
Device Manufacturer Date2007-03-01
Date Added to Maude2008-02-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactDR. DAVID BARCH
Manufacturer Street100 ABBOTT PARK ROAD
Manufacturer CityABBOTT PARK IL 600646092
Manufacturer CountryUS
Manufacturer Postal600646092
Manufacturer Phone8479379328
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameABBOTT HTLV-I/HTLV-II-EIA
Generic NameEIA FOR DETECTION OF HTLV-I HTLV-II ANTIBODIES
Product CodeLRM
Date Received2007-08-09
Model NumberNA
Catalog Number7A92-32
Lot Number51243M200
ID NumberNA
Device Expiration Date2008-01-18
OperatorOTHER
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Implant FlagN
Date RemovedB
Device Sequence No1
Device Event Key948869
ManufacturerABBOTT LABORATORIES
Manufacturer Address100 ABBOTT PARK ROAD ABBOTT PARK IL 600643500 US


Patients

Patient NumberTreatmentOutcomeDate
10 2007-08-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.